Back

Editas Medicine Quote, Financials, Valuation and Earnings

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.

Sell

EDIT
Editas Medicine

Last Price:

5.62

Seasonality Move:

4.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon's Secret "A.I. 2.0" Project

Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project

Editas Medicine Price Quote

$5.62

+0.17 (+3.02%)

(Updated: May 2, 2024 at 6:55 PM ET)

Editas Medicine Key Stats

Sell

Editas Medicine (EDIT) is a Sell

Day range:

$5.21 - $5.67

52-week range:

$5.11 - $11.91

Dividend yield:

P/E ratio:

0.00

P/S ratio:

5.30

P/B ratio:

1.28%

Volume:

Avg. volume:

1.7M

1-year change:

-34.28%

Market cap:

$446.3M

Revenue:

$78.1M

EPS:

$-2.05

How Much Does Editas Medicine Make?

How Much Are Editas Medicine's Sales Annually?
EDIT Revenues are $78.1M
How Much Profit Does Editas Medicine's Make A Year?
EDIT net income is -$153.2M

Is Editas Medicine Growing As A Company?

What Is Editas Medicine's Growth Rate Quarterly?
Quarterly YoY revenue growth is 8.19%
What Is Editas Medicine's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Editas Medicine Stock Price Performance

Did Editas Medicine Stock Go Up Last Month?
Editas Medicine share price went down by -25.07% last month
Did EDIT's Share Price Rise Over The Last Year?
EDIT share price fell by -34.28% over the past 1 year

What Is Editas Medicine 52-Week High & Low?

What Is Editas Medicine’s 52-Week High Share Price?
Editas Medicine has traded as high as $11.91 over the past 52 weeks
What Is Editas Medicine’s 52-Week Low Share Price?
Editas Medicine has traded as low as $5.11 over the past 52 weeks

Editas Medicine Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Editas Medicine?

How Much Debt Does Editas Medicine Have?
Total long term debt quarterly is $0
How Much Cash Does Editas Medicine Have?
Cash and short term investments quarterly total is $323.1M
What Is Editas Medicine’s Book Value Per Share?
Book value per share is 4.27

Is Editas Medicine Cash Flow Positive?

What Is EDIT Cash Flow From Operations?
Cash flow from operations (TTM) is -$132.2M
What Is Editas Medicine’s Cash Flow From Financing?
Cash flow from financing (TTM) is $118M
What Is Editas Medicine’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$3.7M

Editas Medicine Return On Invested Capital

Is Management Doing A Good Job?
EDIT return on invested capital is -42.86%
What Is Editas Medicine Return On Assets?
ROA measures how assets are converting to revenues and is -30.35%
What Is EDIT Return On Equity?
ROE is a measure of profitability and is -42.86%

Editas Medicine Earnings Date & Stock Price

What Is Editas Medicine's Stock Price Today?
A single share of EDIT can be purchased today for 5.46
What Is Editas Medicine’s Stock Symbol?
Editas Medicine trades on the nasdaq under the ticker symbol: EDIT
When Is Editas Medicine’s Next Earnings Date?
The next quarterly earnings date for Editas Medicine is scheduled on May 3, 2024
When Is EDIT's next ex-dividend date?
Editas Medicine's next ex-dividend date is May 3, 2024
How To Buy Editas Medicine Stock?
You can buy Editas Medicine shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Editas Medicine Competitors

Who Are Editas Medicine's Competitors?
Below is a list of companies who compete with Editas Medicine or are related in some way:
- Amicus Therapeutics Inc (FOLD)
- Geron Corp (GERN)
- Moderna Inc (MRNA)
- Regeneron Pharmaceuticals Inc (REGN)
- Vertex Pharmaceuticals Inc (VRTX)

Editas Medicine Dividend Yield